See More Hear More Watch More Hear More Get on iTunes
NYT Business NYTimesBusiness

J.&J. to Pay $2.2 Billion in Risperdal Settlement

Johnson and Johnson has agreed to pay more than 2 billion dollars in criminal and civil fines to settle accusations it improperly promoted a drug as a way to treat dementia patients for many ailments, when it was only approved for one. Full Story: http://www.nytimes.com/2013/11/05/business/johnson-johnson-to-settle-risperdal-improper-marketing-case.html

UP NEXT

More from